logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Biotechnology
Filter

Biotechnology

Categories

Sectors

Locations

Exchange

AI驱动未来医疗,BioNTech股价应声上涨近4%

Want to Build Real Wealth in the Healthcare Sector? These Stocks Are Worth Considering

Apr 30, 2026

Life Science

Eli Lilly Locks In Retatrutide FDA Filing Date — Can the Stock Climb to $1,750 by 2027?

Bristol Myers Squibb Beats on Q1 Sales, Profit; Stock Jumps 5% as Growth Portfolio Shines

Apr 30, 2026

Life Science

Shorted-to-the-hilt KalVista rockets 39% as Chiesi swoops in with $1.9bn cash bid

Shorted-to-The-Hilt KalVista Rockets 39% as Chiesi Swoops in With $1.9bn Cash Bid

Apr 29, 2026

Life Science

High-Yield Healthcare Plays: MPT and Pfizer Offer 7% and 6.4% Dividends as Markets Turn Choppy

High-Yield Healthcare Plays: MPT and Pfizer Offer 7% and 6.4% Dividends as Markets Turn Choppy

Apr 28, 2026

Life Science, Real Estate

Vertex Tops Q2 Estimates, But Investors Shift Focus to Crinetics Deal Integration

Organon Shares Extend Rally as India’s Sun Pharma Strikes $11.75 Billion All-Cash Deal

Apr 27, 2026

Life Science

Why Moderna and Regeneron Look Like Long-Term Bargains Amid the Selloff

Why Moderna and Regeneron Look Like Long-Term Bargains Amid the Selloff

Apr 21, 2026

Life Science

Trump Orders Fast-Track for Psychedelic Therapies—Who Stands to Win the Most?

Trump Orders Fast-Track for Psychedelic Therapies—Who Stands to Win the Most?

Apr 20, 2026

Life Science

Vertex Tops Q2 Estimates, But Investors Shift Focus to Crinetics Deal Integration

Lilly in Advanced Talks to Acquire Kelonia for Over $2 Billion—Is a 39x P/E Still Too Rich?

Apr 19, 2026

Life Science

Kone Nears TK Elevator Deal at EUR 25B; OTIS in Focus

Apr 17, 2026

Life Science

押注未来:瞄准2026年高增长潜力的两家生物科技公司

Low-Key but Strong, Three Overlooked Biotech Stocks Worth Watching

Apr 16, 2026

Life Science

The 21-mile choke point running global finance

Apr 16, 2026

Life Science

Rice Surge Reveals the Chokepoint Economy

Apr 15, 2026

Life Science

J&J Q1 Beat Reveals the Unvarnished Truth Behind 63 Years of Dividend Growth

J&J Q1 Beat Reveals the Unvarnished Truth Behind 63 Years of Dividend Growth

Apr 14, 2026

Life Science

KRYS, EXEL, CVS: Beating the Market, with More to Come

Why Institutions Are Turning Bullish on Biohaven—and the Catalyst That Could Unlock Its Value

Apr 13, 2026

Life Science

Apple and Nvidia Tussle for World’s Most Valuable Crown — Which Is the Better Buy?

Oral Weight-Loss Era: Who Has More Staying Power—Novo Nordisk or Eli Lilly?

Apr 9, 2026

Life Science

Three Biotech Stocks Crushed the S&P 500 — Analysts Still Back Just One

Axsome’s Decade of 33% Returns Puts Focus on $16 Billion Pipeline

Apr 8, 2026

Life Science

Berkshire Pours $10B Into Alphabet, Which Outperforms Nvidia This Year

Eli Lilly Writes a Check. AC Immune Surges 15%. Is This Strategy or Spare Change?

Apr 7, 2026

Life Science

FDA’s Wrath Sends ImmunityBio Stock Down Over 3%

FDA’s Wrath Sends ImmunityBio Stock Down Over 3%

Apr 7, 2026

Life Science

  • ‹‹ Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada